J&J Unit Recalls Antipsychotic Syringes Over Cracks

Law360, New York (February 16, 2011, 6:42 PM EST) -- Johnson & Johnson unit Janssen has voluntarily recalled 70,000 syringes with the antipsychotic drug Invega Sustenna, saying some may contain cracks that pose a possible infection risk.

Titusville, N.J.-based Janssen, part of the pharmaceutical and medical device giant's Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary, published a letter dated Friday saying it had recalled 10 lots of 234-milligram doses of its Invega Sustenna, or paliperidone palmitate, extended-release injectable suspension.

Some of the prefilled syringes could contain a crack in the syringe barrel that would not be detectable by the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.